Skip to content

Lonidamine

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

Also known as: diclondazolic acid, doridamina

ATC L01XX07

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Lonidamine is a drug catalogued in DrugCentral. DrugCentral lists 3 molecular targets, including Mpc2, MPC2 and MPC1L. Recorded indications include Malignant tumor of lung.

  • Molecular targets: Mpc2, MPC2 and MPC1L (3 listed in DrugCentral).
  • Indications: Malignant tumor of lung.
  • ATC code: L01XX07 (Other antineoplastic agents).
  • Molecular formula: C15H10Cl2N2O2; molecular weight 321.16 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Malignant tumor of lung

Mechanism & targets

Molecular targets (3)

TargetGeneActionActivity
Mitochondrial pyruvate carrier 2Mpc2inhibitorIC50 5.60
Mitochondrial pyruvate carrier 2MPC2inhibitorIC50 5.34
Mitochondrial pyruvate carrier 1-like proteinMPC1LinhibitorIC50 5.34

ATC classification

ATC codeTherapeutic hierarchy
L01XX07ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS › ANTINEOPLASTIC AGENTS › OTHER ANTINEOPLASTIC AGENTS › Other antineoplastic agents

Chemical structure

Molecular formulaC15H10Cl2N2O2
Molecular weight321.16 g/mol
CAS number50264-69-2
InChIKeyWDRYRZXSPDWGEB-UHFFFAOYSA-N
PubChem CID39562
OC(=O)C1=NN(CC2=C(Cl)C=C(Cl)C=C2)C2=C1C=CC=C2

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Lonidamine used for?

DrugCentral lists the following indications for Lonidamine: Malignant tumor of lung.

How does Lonidamine work?

Its molecular targets in DrugCentral include Mpc2 (inhibitor), MPC2 (inhibitor) and MPC1L (inhibitor).

What is the chemical formula of Lonidamine?

Lonidamine has the molecular formula C15H10Cl2N2O2 and a molecular weight of 321.16 g/mol.

Browse: all drugs starting with L · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets3
Indications1
FormulaC15H10Cl2N2O2
DrugCentral ID1598
Interactive profile